Drug Trial Radar · NCT03354598
Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women
Last checked: Nov 19, 2026Latest source record: Jan 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,671
Actual
Start
Aug 1, 2018
Primary completion
Jan 16, 2020
Study completion Jan 20, 2020
Sponsor
- Lead sponsor
- Iterum Therapeutics, International LimitedIndustry
- Sponsor type
- Industry
- First posted
- Nov 28, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy, tolerability, and safety of oral sulopenem-etzadroxil/probenecid versus oral ciprofloxacin for treatment of uncomplicated urinary tract infection (uUTI) in adult women
Conditions
- Uncomplicated Urinary Tract Infections
Interventions
Sulopenem-Etzadroxil/ProbenecidDrug
Treatment of uncomplicated urinary tract infection
CiprofloxacinDrug
Treatment of uncomplicated urinary tract infection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants With Overall SuccessTime frame: Day 12+/-1 day
- Percentage of Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants With Overall SuccessTime frame: Day 12 +/- 1 day
Locations
60 sites in 1 country. Site status is shown where the registry gives one.
Medical Facility
Birmingham, Alabama
Medical Facility
Phoenix, Arizona
Medical Facility
Tolleson, Arizona
Medical Facility
Cerritos, California
Medical Facility
Chula Vista, California
Medical Facility
Fullerton, California
Medical Facility
La Mesa, California
Medical Facility
Los Angeles, California
Medical Facility
San Diego, California
Medical Facility
Sylmar, California
Medical Facility
Washington D.C., District of Columbia
Medical Facility
Bradenton, Florida
Medical Facility
Clearwater, Florida
Medical Facility
Doral, Florida
Medical Facility
Edgewater, Florida
Medical Facility
Hialeah, Florida
Medical Facility
Lauderdale Lakes, Florida
Medical Facility
Miami, Florida
Medical Facility
Miami, Florida
Medical Facility
Miami, Florida
Medical Facility
Miami, Florida
Medical Facility
Miami, Florida
Medical Facility
Miami, Florida
Medical Facility
Miami, Florida
Medical Facility
Miami, Florida
Medical Facility
Miami Springs, Florida
Medical Facility
New Port Richey, Florida
Medical Facility
Ormond Beach, Florida
Medical Facility
Palmetto Bay, Florida
Medical Facility
St. Petersburg, Florida
Medical Facility
Winter Haven, Florida
Medical Facility
Atlanta, Georgia
Medical Facility
Norcross, Georgia
Medical Facility
Perry, Georgia
Medical Facility
Lake Charles, Louisiana
Medical Facility
Metairie, Louisiana
Medical Facility
New Orleans, Louisiana
Medical Facility
Las Vegas, Nevada
Medical Facility
Las Vegas, Nevada
Medical Facility
Brooklyn, New York
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.